Although higher anti-S protein antibody titers have been suggested as important precursors for the strength and duration of immunity [26], real-world vaccine efficacy depends also on innate immunity and external factors such as the type of variants that are circulating and people’s behavior patterns and their level of daily exposure to COVID-19. Here, PROS1 is linked to COVID-19.